View in EDS HTML Full Text PDF Full Text

Role of the tumor board when prescribing mutant isocitrate dehydrogenase inhibitors to patients with isocitrate dehydrogenase-mutant glioma.

Saved in:

Bibliographic Details
Title:	Role of the tumor board when prescribing mutant isocitrate dehydrogenase inhibitors to patients with isocitrate dehydrogenase-mutant glioma.
Authors:	Roth, Patrick^1,2 (AUTHOR), Capper, David^3,4 (AUTHOR), Calabrese, Evan⁵ (AUTHOR), Halasz, Lia M⁶ (AUTHOR), Jakola, Asgeir S^7,8 (AUTHOR)
Source:	Neuro-Oncology Practice. 2025 Supplement, Vol. 12, pi29-i37. 9p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Description
ISSN:	20542577
DOI:	10.1093/nop/npae100